Prolactin antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Prolactin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to Hormones diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-184-11. BSA-Prolactin
2. Anti-Prolactin mouse monoclonal antibody
$2709.00
GMP-SMT-184-21. OVA-Prolactin
2. Anti-Prolactin mouse monoclonal antibody
$2709.00
GMP-SMT-184-31. BSA-Prolactin
2. Anti-Prolactin human monoclonal antibody
$2709.00
GMP-SMT-184-41. OVA-Prolactin
2. Anti-Prolactin human monoclonal antibody
$2709.00
GMP-SMT-184-Ag-1BSA-Prolactin$756.00
GMP-SMT-184-Ag-2OVA-Prolactin$756.00
GMP-SMT-184-Ab-1Anti-Prolactin mouse monoclonal antibody$1953.00
GMP-SMT-184-Ab-2Anti-Prolactin human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Prolactin

Cat No.GMP-SMT-184-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Prolactin with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Prolactin had been validated with our anti-Hapten antibody Anti-Prolactin mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Prolactin

Cat No.GMP-SMT-184-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Prolactin with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Prolactin had been validated with our anti-Hapten antibody Anti-Prolactin mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Prolactin mouse monoclonal antibody

Cat No.GMP-SMT-184-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.4-0.5
Products descriptionThe anti-Hapten antibody against hapten Prolactin had been validated with our hapten hapten-carrier conjugates BSA-Prolactin via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Prolactin human monoclonal antibody

Cat No.GMP-SMT-184-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.4-0.5
Products descriptionThe anti-Hapten antibody against hapten Prolactin had been validated with our hapten hapten-carrier conjugates BSA-Prolactin via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Biomarker Information


    1. Prolactin: Its Role in In Vitro Diagnosis

    Serial Number 1: Prolactin, scientifically denoted as PRL, is a biologically significant peptide hormone primarily synthesized within the anterior pituitary gland, a pivotal endocrine structure nestled within the confines of the cerebral region. Although prolactin's foremost claim to fame rests in its principal role of stimulating mammary glands, thereby facilitating milk production during lactation, this multifaceted hormone extends its influence across a spectrum of physiological functions.

    Within the purview of in vitro diagnosis, prolactin emerges as a conspicuous and versatile biomarker, affording valuable insights into a diverse array of health conditions and disorders. While its notability as a lactogenic hormone is well-established, it is imperative to acknowledge the broader panorama of its physiological implications, particularly in the context of clinical diagnostics.

    Elevated levels of prolactin within the bloodstream assume diagnostic significance, as they can serve as a red flag for a multitude of medical conditions, most notably hyperprolactinemia—a condition characterized by the excessive production of prolactin—as well as the presence of pituitary tumors that exert influence over hormone regulation. Prolactin plays a vital role as a biochemical indicator of these health anomalies.

    In the field of endocrinology and clinical diagnostics, the quantification of prolactin levels in serum or plasma samples stands as a cornerstone of investigative practice. This measurement furnishes healthcare practitioners with an instrumental diagnostic tool, one that serves as a sentinel for hormonal imbalances and related disorders. Conditions such as hyperprolactinemia, marked by clinical manifestations such as irregular menstruation, infertility, and the occurrence of galactorrhea (the inappropriate secretion of milk), find expedient diagnosis through prolactin testing.

    Moreover, the measurement of prolactin bears substantive relevance in the evaluation of pituitary gland functionality and its intricate interplay with other constituents of the endocrine apparatus. This diagnostic modality enriches the diagnostic armamentarium of healthcare practitioners, bolstering their capacity to craft accurate and efficacious treatment plans and therapeutic interventions for individuals grappling with a litany of hormonal irregularities.

    In summary, prolactin emerges as an indomitable biomarker of pivotal importance within the purview of in vitro diagnosis. Its capacity to unveil the presence and progression of hormonal disorders, most conspicuously hyperprolactinemia, renders it indispensable in the healthcare landscape. Beyond its more celebrated role in lactation, prolactin's measurement enshrines it as a linchpin in the orchestration of timely and precise clinical assessments and therapeutic strategies.

    2. The Significance of Prolactin Measurement

    Serial Number 2: Prolactin measurement unfurls its layers of significance across diverse domains, underpinned by several compelling rationales, each emblematic of its paramount import within clinical practice and medical research:

    a. Diagnosis of Hormonal Disorders: Elevated levels of prolactin within the bloodstream serve as a reliable harbinger of hormonal disorders, most notably hyperprolactinemia, hypopituitarism, or the presence of pituitary tumors. The precise measurement of prolactin levels assumes a diagnostic mantle, facilitating the timely detection of these conditions, thereby equipping clinicians with the requisite data to craft meticulously tailored treatment regimens.

    b. Evaluation of Fertility Issues: Within the sphere of female reproductive health, prolactin measurement holds an exalted position in the assessment of fertility-related issues. The identification and management of hyperprolactinemia are pivotal for enhancing fertility outcomes, as elevated prolactin levels can impede regular menstrual cycles and contribute to infertility.

    c. Monitoring Treatment Efficacy: Patients navigating the labyrinth of therapeutic interventions for prolactin-related disorders, often involving the administration of dopamine agonists, necessitate periodic monitoring of prolactin levels. This measurement serves as a barometer for gauging the effectiveness of treatment regimens and facilitates the judicious adjustment of therapeutic strategies when warranted.

    d. Detection of Pituitary Tumors: Elevated prolactin levels can serve as a clinical harbinger of the presence of pituitary tumors, notably prolactinomas. Early detection of these neoplasms is of profound clinical value, as it paves the way for timely interventions and the formulation of treatment strategies that may prevent further complications.

    e. Insight into Hormonal Dynamics: Beyond its utility as a diagnostic biomarker, prolactin measurement enriches our understanding of pituitary gland functionality and its intricate interactions within the broader hormonal milieu. This, in turn, contributes to the unraveling of the intricate tapestry of hormonal balance within the endocrine system, fostering a nuanced comprehension of physiological intricacies.

    f. Clinical Decision-Making: Within the realm of healthcare, the measurement of prolactin levels stands as a sentinel for evidence-based clinical decision-making. It empowers healthcare practitioners to make informed, data-driven choices in patient care, enhances treatment precision, and ultimately augments patient well-being, constituting an invaluable facet of contemporary medical practice.

    In summation, the measurement of prolactin unfurls as an indomitable pillar of clinical practice and medical research, its significance underscored by its multifaceted utility. Whether facilitating the diagnosis of hormonal disorders, the evaluation of fertility issues, or the monitoring of treatment efficacy, prolactin measurement remains an indispensable tool for clinicians and researchers alike. Its pivotal role in healthcare decision-making crystallizes into improved patient outcomes and the promotion of overall health.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.